background: despite the prevalence of non-alcoholic fatty liver disease (nafld) and non-alcoholic steatohepatitis (nash), no treatment has been proven to be effective in these common diseases. although many studies have shown that lifestyle modifications such as increasing physical activities and exercise could be effective in the treatment of these common diseases, the optimal strategy is stil...

Non-alcoholic fatty liver disease (NAFLD) is one of chronic and defines by fat accumulation ≥5% in which can progresses to non-alcoholic steatohepatitis (NASH). NAFLD related obesity as well non obese individuals. Adiponectin a cytokine secreted from adipose tissue involved pathogenesis liked with obesity. Irisin myokine, has convenient effect against metabolic diseases such obesity, disylipemi...

Non-alcoholic fatty liver disease (NAFLD) is a heterogeneous disease that may range from simple steatosis (non-alcoholic fatty liver, NAFL) to non-alcoholic steatohepatitis (NASH) which can progress to advanced fibrosis and cirrhosis and is currently one of the most common chronic liver diseases in Korea and worldwide. Furthermore, in parallel with the increasing prevalence of obesity, type 2 d...

Background and Aims:Patatin-like phospholipase domain protein 3 (PNPLA3) polymorphisms (rs738409 C>G) are associated with non-alcoholic fatty liver disease (NAFLD). We performed a systematic review and meta-analysis to examine the association of PNPLA3 polymorphisms with the spectrum and severity of this disease. Methods: Studies evaluating the association between the PNPLA3 polymorphism spectr...